Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Helius Medical Technologies, Inc. HSDT
$0.16
-$0.01 (-8.77%)
На 18:01, 12 мая 2023
+3 025.00%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
4866467.00000000
-
week52high
2.76
-
week52low
0.14
-
Revenue
787000
-
P/E TTM
0
-
Beta
1.21868500
-
EPS
-0.86000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 12:30
Описание компании
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Noble Capital Markets | Outperform | 24 мар 2021 г. | |
| BTIG Research | Neutral | Buy | 16 апр 2019 г. |
| Oppenheimer | Perform | Outperform | 11 апр 2019 г. |
| Oppenheimer | Outperform | 06 мар 2019 г. | |
| BTIG Research | Buy | Neutral | 20 ноя 2018 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| ANDREEFF DANE | A | 15752 | 2313 | 16 дек 2022 г. |
| ANDREEFF DANE | A | 332517 | 25594 | 16 дек 2022 г. |
| ANDREEFF DANE | A | 62893 | 8868 | 16 дек 2022 г. |
| ANDREEFF DANE | A | 304323 | 43266 | 16 дек 2022 г. |
| ANDREEFF DANE | A | 13439 | 2509 | 23 ноя 2022 г. |
| ANDREEFF DANE | A | 306923 | 30841 | 23 ноя 2022 г. |
| ANDREEFF DANE | A | 54025 | 10105 | 23 ноя 2022 г. |
| ANDREEFF DANE | A | 261057 | 42185 | 23 ноя 2022 г. |
| ANDREEFF DANE | A | 13528 | 2598 | 23 ноя 2022 г. |
| ANDREEFF DANE | A | 308003 | 31921 | 23 ноя 2022 г. |
Новостная лента
Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023
GlobeNewsWire
04 мая 2023 г. в 16:05
NEWTOWN, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its first quarter 2023 financial results on Thursday, May 11, 2023, after the market closes.
7 Sorry Pharma Stocks to Sell in April Before It's Too Late
InvestorPlace
16 апр 2023 г. в 06:30
Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or treatment, the rewards can be extreme, but investing in pharma stocks can also mean heavy expenditures on research and testing for a drug that may not perform as well as scientists hope.
Helius Medical Technologies, Inc. (HSDT) Q4 2022 Earnings Call Transcript
Seeking Alpha
10 мар 2023 г. в 18:19
Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q4 2022 Earnings Conference Call March 9, 2023 4:30 PM ET Company Participants Michelle Bilski - In-Site Communications Dane Andreeff - President & Chief Executive Officer Jeffrey Mathiesen - Chief Financial Officer Antonella Favit-Van Pelt - Chief Medical Officer Conference Call Participants Jonathan Aschoff - ROTH MKM Partners Destiny Hance - Ladenburg Thalmann Anthony Vendetti - Maxim Group Operator Good day, and thank you for standing by. Welcome to the Helius Medical Technologies Fourth Quarter and Year-End 2022 Earnings Conference Call.
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
GlobeNewsWire
06 мар 2023 г. в 07:30
NEWTOWN, Pa., March 06, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, after the market closes.
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
GlobeNewsWire
02 мар 2023 г. в 16:05
NEWTOWN, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the 35th Annual ROTH Conference, March 12-14, 2023, Laguna Nigel, CA, as follows: